Email a Friend
Print ArticleProstate Cancer Health Center
This article is from the WebMD News Archive
Prostate Cancer: Black-White Race Gap
March 12, 2007 -- When it comes to diagnosing prostate cancer at an early stage, black men's biggest hurdle may be poor access to trusted medical care.
So say researchers including James Talcott, MD, SM, of the Center for Outcomes Research at Massachusetts General Hospital.
They studied 555 men -- 348 whites and 207 blacks -- newly diagnosed with prostate cancer and living in North Carolina.
The men completed surveys about their medical history, personal backgrounds, access to medical care, and trust in doctors.
The study shows that black men knew about their risk but faced disadvantages in access to medical care.
Better access to medical care may help black men get diagnosed with prostate cancer sooner, the researchers note.
Aware of Risk
The study appears in the April 15 edition of Cancer.
The patients were at least 41 years old. Blacks tended to be younger than whites.
Black men were more likely to have lower-income jobs, no health insurance, and blue-collar jobs. They were also more likely to get their medical care in emergency rooms, not doctors' offices.
Black men are more likely than white men to die of prostate cancer, and the black men in this study reported knowing that they were at increased risk for prostate cancer before diagnosis.
Paul Godley, MD, PhD, worked with Talcott and colleagues on the study. Godley is on staff at the schools of public health and medicine at the University of North Carolina at Chapel Hill.
"African American men were aware of their increased risk of prostate cancer, and they felt responsible for getting themselves to physicians for preventative care. But there were substantial barriers to their carrying out what they saw as being important," Godley says in a UNC news release.
Distrust of Doctors
Most men -- black or white -- expressed trust in their doctors. But 85% of black men reported 'completely" or "mostly" trusting their doctors, compared with 96% of white men.
That may be because black men were more likely to go to emergency rooms for medical care, where they might not always see the same doctor, the researchers note.
"If you don't have a doctor and have to repeat your whole history to an emergency room physician every time you have a medical encounter, then it's harder to develop trust in physicians," Godley says. "Lack of trust seemed to stem from the lack of a regular source of health care.
Cultural suspicion of doctors and medical care didn't seem to be a big issue among the black men.
"This wasn't coming from some historical distrust from previous abuses but was coming from people's own experience with the health care system," Godley says.
Black men were also more likely than whites to say they requested prostate cancer screening, while whites generally said their doctors recommended prostate cancer screening tests. The reasons for that race gap aren't clear.
"The reassuring part of the findings is that measures to generally make health care more accessible would also potentially address some of the disparities in prostate cancer," Godley says.
del.icio.us
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.
Symptoms of an Enlarged Prostate
Sheldon Marks, MD, explains nearly everything you need to know about an enlarged prostate but were afraid to ask.
